- Enforcing jurisdiction
- Norway · Geography does not establish applicable law.
- Confirmed applicable legislation
- Privacy topics
Lab Pharma AS – €17,835 Fine (Norway, 2026)
Privacy enforcement record
This record is classified outside cookie consent. Subject classification does not confirm an applicable law. It is not included in cookie statistics or the Risk Calculator.
Lab Pharma AS in Norway was fined for continuing to use a social media influencer's personal data after their agreement had expired. The company failed to erase the data when requested, violating GDPR rules. This case highlights the importance of respecting individuals' rights regarding their personal information.
What happened
Lab Pharma AS continued to process a social media influencer's personal data without a valid legal basis after their agreement ended.
Who was affected
The social media influencer whose personal data was used without consent.
What the authority found
The Norwegian Data Protection Authority imposed a fine on Lab Pharma for processing personal data unlawfully and failing to comply with erasure requests.
Why this matters
This ruling reinforces the need for companies to have clear policies regarding data usage and to respect individuals' rights to control their personal information. It serves as a cautionary tale for businesses about the consequences of non-compliance.
View original scraped data
Original imported citations before automated processing; the processing history does not establish independent verification.
Source checks
Secondary-source text retrieved.
Automated check recorded — 22 August 2026.
Processing notes: articles corrected.
Retrieved text may be a secondary summary or an announcement. These automated statuses do not establish that the original decision was read or that the record received an independent legal review. How we check sources
Lab Pharma AS, the controller, is a Norwegian manufacturer of dietary supplements which markets and sells its products online. In 2016, an influencer, the data subject, entered into an agreement with the controller under which she would promote its products on her blog and social media profiles. The agreement also allowed the controller to use excerpts of her posts, including images, audio and text, in its own marketing. After the agreement had expired, the controller continued using the data subject’s name, photographs and comments about its products on its websites. In February 2023, the data subject requested the erasure of her personal data under Article 17 GDPR. The controller rejected the request, claiming that the agreement entitled it to continue using the data and stating that it would not respond to further inquiries. The data subject lodged a complaint with the DPA arguing that the controller lacked a legal basis for the processing and requesting the erasure of her personal data. In July 2024, the DPA initiated an investigation and ordered the controller to provide information concerning the processing. The controller challenged the DPA’s competence and refused to provide the agreement underlying the processing, arguing that it was confidential. The Privacy Appeals Board subsequently upheld the DPA’s information order. During the investigation, the controller repeatedly delayed providing requested information and documentation and its CEO sent numerous communications seeking to have the investigation discontinued, including threats of legal action and police reports against DPA employees. The DPA held that the controller processed the data subject’s personal data without a valid legal basis under Article 6(1) GDPR and failed to comply with its obligations under Articles 17, 21 and 31 GDPR. Regarding Article 6(1)(b) GDPR, the DPA rejected the controller’s argument that the processing remained necessary for the performance of the agreement. The agreement expressly had a duration of one year and expired in March 2017. Nothing in its wording established that the controller could continue using the data subject’s personal data after its expiry. Consequently, Article 6(1)(b) GDPR could no longer provide a legal basis for the processing. The controller also relied on legitimate interests under Article 6(1)(f) GDPR. The DPA noted that the fact that personal data had previously been made publicly available did not remove the requirement for a legal basis. Moreover, the data subject’s request to stop the processing constituted an objection under Article 21(1) GDPR. Since the controller failed to demonstrate compelling legitimate grounds overriding the data subject’s interests, it was required to cease the processing. As the processing was unlawful, the controller was also required under Article 17 GDPR to erase the personal data without undue delay. The DPA therefore ordered the controller to delete the data subject’s personal data from all websites it operated and to cease using her personal data for marketing purposes unless it obtained a lawful basis for doing so. Regarding Article 31 GDPR, the DPA held that the duty to cooperate requires controllers to facilitate supervisory investigations and comply with lawful information requests and deadlines. Attempts to delay or halt an investigation may breach Article 31 GDPR even where the supervisory authority is ultimately able to complete its investigation. The controller had intentionally attempted to obstruct the investigation through threats and pressure on DPA employees and had also negligently failed to comply with several deadlines for providing requested documentation. The DPA considered these circumstances sufficiently serious to warrant an administrative fine and imposed a fine of NOK 205,000 for the infringement of Article 31 GDPR. The decision cannot be appealed to the Privacy Appeals Board but may be challenged before the Oslo District Court.
Related Enforcement Actions (0)
No other enforcement actions found for Lab Pharma AS in NO
This is the only recorded action for this entity in this jurisdiction.
Details
Fine Date
12 August 2026
Authority
Datatilsynet (Norway)
Fine Amount
€17,835
205,000 NOK
GDPRhub ID
gdprhub-10206About this data
Cite as: Cookie Fines. Lab Pharma AS - Norway (2026). Retrieved from cookiefines.eu
Last updated: